ABC | Volume 114, Nº5, May 2020

Statement Brazilian Cardiology Society Statement for Management of Pregnancy and Family Planning in Women with Heart Disease – 2020 Arq Bras Cardiol. 2020; 114(5):849-942 157. Abildgaard U, Sandset PM, Hammerstrom J, Gjestvang FT, Tveit A. Management of pregnant womenwithmechanical heart valve prosthesis: Thromboprophylaxis with low molecular weight heparin. Thromb Res. 2009;124(3):262-7. 158. Friedrich E, Hameed AB. Fluctuations in anti-factor Xa with therapeutic enoxaparian during pregnancy. J Perinatol. 2010;30(4):253-7. 159. Goland S, Schwartzenberg S, Fan J, Kozak N, Khatri N, Elkayam U. Monitoringof anti-Xa in pregnant patients with mechanical prosthetic valves receiving lowmolecular-weight heparin: Peak or trough levels? J Cardiovasc Pharmacol Ther. 2014;19(5):451-6. 160. D’Souza R, Ostro J, Shah PS, Silversides CK, Malinowski A, Murphy KE, et al. Anticoagulation for pregnant women with mechanical heart valves: A systematic review and meta-analysis. Eur Heart J. 2017;38(19):1509-16. 161. SousaAR,BarreiraR,SantosE.Low-dosewarfarinmaternalanticoagulation and fetal warfarin syndrome. BMJ Case Rep. 2018 Apr 7;2018. pii: bcr- 2017-223159. 162. Basu S, Aggarwal P, Kakani N, Kumar A. Low-dosematernal warfarin intake resulting in fetal warfarin syndrome: In search for a safe anticoagulant regimen during pregnancy. Birth Defects Res A Clin Mol Teratol. 2016;106(2):142-7. 163. Van Driel D, Wesseling J, Sauer PJ, Touwen BC, van der Veer E, Heymans HS. Teratogen update: Fetal effects after in utero exposure to coumarins overview of cases, follow-up findings, and pathogenesis. Teratology. 2002;66(3):127-40. 164. Marelli AJ, Ionescu-Ittu R, Mackie AS, Guo L, Dendukuri N, KaouacheM. Lifetime prevalence of congenital heart disease in the general population from 2000 to 2010. Circulation. 2014;130(9):749-56. 165. Balint OH, Siu SC, Mason J, Grewal J, Wald R, Oechslin EN, et al. Cardiac outcomes after pregnancy in womenith congenital heart disease. Heart. 2010;96(20):1656-61. 166. Cantwell R, Clutton-Brock T, Cooper G, Dawson A, Drife J, Garrod D, et al. Saving Mothers' Lives: Reviewing maternal deaths to make motherhood safer: 2006-2008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG. 2011;118(Suppl 1):1-203. 167. Sliwa K, van Hagen IM, Budts W, Swan L, Sinagra G, Caruana M, et al. Pulmonary hypertension and pregnancy outcomes: Data from the Registry of Pregnancy and Cardiac Disease (ROPAC) of the European Society of Cardiology. Eur J Heart Fail. 2016;18(9):1119-28. 168. Ávila WS, Grinberg M, Snitcowsky R, Faccioli R, Da Luz PL, Bellotti G, et al. Maternal and fetal outcome in pregnant women with Eisenmenger´s syndrome. Eur Heart J. 1995;16(4):460-4 169. Ladoucer M, Benoit L, Basquin A, Radojevic J, Hauet Q, Hascoet S, et al. How pregnancy impacts adult cyanotic congenital heart disease. Circulation. 2017;135(24):2444-7. 170. Presbitero P, Somerville J, Stone S, Aruta E, Spiegelhalter D, Rabajoli F. Pregnancy in cyanotic congenital heart disease. Outcome of mother and fetus. Circulation. 1994;89(6):2673-6. 171. Canobbio MM, Warnes CA, Aboulhosn J, Connolly HM, Khanna A, Koos BJ, et al. Management of pregnancy in patients with complex congenital heart disease A Scientific Statement for Healthcare Professionals From the American Heart Association. Circulation. 2017;135(8):e50-87. 172. Jais X, Olsson KM, Barbera JA, Blanco I, Torbicki A, Peacock A, et al. Pregnancy outcomes in pulmonary arterial hypertension in the modern management era. Eur Respir J. 2012;40(4):881-5. 173. Bendayan D, Hod M, Oron G, Sagie A, Eidelman L, Shitrit D, et al. Pregnancy outcome in patients with pulmonary arterial hypertension receiving prostacyclin therapy. Obstet Gynecol. 2005;106(5 Pt 2):1206-10. 174. Duarte AG, Thomas S, Safdar Z, Torres F, Pacheco LD, Feldman J, et al. Management of pulmonary arterial hypertension during pregnancy: A retrospective, multicenter experience. Chest. 2013;143(5):1330-6. 175. Duan R, Xu X, Wang X, Yu H, You Y, Liu X, et al. Pregnancy outcome in womenwithEisenmenger’ssyndrome:Acaseseries fromwestchina.BMC Pregnancy Childbirth. 2016;16(1):356. 176. Cha KS, Cho KI, Seo JS, Choi JH, Park YH, Yang DH, et al. Effects of inhaled iloprost on exercise capacity, quality of life, and cardiac function in patients with pulmonary arterial hypertension secondary to congenital heart disease (the Eisenmenger syndrome) (from the EIGER Study). Am J Cardiol. 2013;112(11):1834-9. 177. Yap SC, Drenthen W, Meijboom FJ, Moons P, Mulder BJ, Vliegen HW, et al. Comparison of pregnancy outcomes in women with repaired versus unrepaired atrial septal defect. BJOG. 2009;116(12):1593-601. 178. Sawlani N, Shroff A, Vidovich MI. Aortic dissection and mortality associated with pregnancy in the United States. J Am Coll Cardiol. 2015;65(15):1600-1. 179. Krieger EV, Landzberg MJ, Economy KE, Webb GD, Opotowsky AR. Comparison of risk of hypertensive complications of pregnancy among women with versus without coarctation of the aorta. Am J Cardiol. 2011;107(10):1529-34. 180. Balci A, Drenthen W, Mulder BJ, Roos-Hesselink JW, Voors AA, Vliegen HW, et al. Pregnancy in women with corrected tetralogy of fallot: Occurrence and predictors of adverse events. Am Heart J. 2011;161(2):307-13. 181. Lima FV, Koutrolou-Sotiropoulou P, Yen TY, Stergiopoulos K. Clinical characteristics and outcomes in pregnant women with Ebstein anomaly at the time of delivery in the USA: 2003-2012. Arch Cardiovasc Dis. 2016;109(6-7):390-8. 182. Avila WS, Ribeiro VM, Rossi EG, Binotto MA, Bortolotto MR, Testa C, et al.Pregancy in women with complex congenital heart disease. A constant challenge. Arq Bras Cardiol. 2019;113(6):1062-69 183. Bowater SE, Selman TJ, Hudsmith LE, Clift PF, Thompson PJ, Thorne SA. Longterm outcome following pregnancy in women with a systemic right ventricle: Is the deterioration due to pregnancy or a consequence of time? Congenit Heart Dis. 2013;8(4):302-7. 184. Hornung TS, Bernard EJ, Celermajer DS, Jaeggi E, Howman-Giles RB, Chard RB, et al. Right ventricular dysfunction in congenitally corrected transposition of the great arteries. Am J Cardiol. 1999;84(9):1116-9, A10. 185. Gouton M, Nizard J, Patel M, Sassolas F, Jimenez M, Radojevic J, et al. Maternal and fetal outcomes of pregnancy with Fontan circulation: A multicentric observational study. Int J Cardiol. 2015 Mar;187:84-9. 186. Zentner D, Kotevski A, King I, Grigg L, d’UdekemY. Fertility and pregnancy in the Fontan population. Int J Cardiol. 2016 Apr;208:97-101. 187. Oliveira TA, Avila WS, Grinberg M. Obstetric and perinatal aspects in patients with congenital heart diseases. Sao Paulo Med J. 1996;114(5):1248-54. 188. Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, et al. Classification of the cardiomyopathies: a position statement from the European Society of Cardiology working group on myocardial and pericardial diseases. Eur Heart J. 2008;29(2):270-6 189. Billebeau G, Etienne M, Cheikh-Khelifa R, Vauthier-Brouzes D, Gandjbakhch E, et al. Pregnancy in women with a cardiomyopathy: Outcomes and predictors from a retrospective cohort. Arch Cardiovasc Dis. 2018;111(3):199-209. 190. Siu SC, Sermer M, Colman JM, Alvarez AN, Mercier LA, Morton BC, et al. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation. 2001;104(5):515-21. 934